Dan Van Fleet advises clients on a full spectrum of bespoke and complex financing transactions.

Dan represents companies and lenders, as well as venture capital, private equity, and other private capital firms, in debt and debt-like hybrid financings, particularly in the technology and life sciences industries. 

He leverages a commercial perspective and creative approach to provide clients with innovative and effective funding solutions. A trusted strategic advisor, Dan regularly advises companies on their highest-stakes financing transactions involving:

  • Growth debt, including venture, structured, royalty, and lower middle market
  • Private capital, private equity, growth equity, and leveraged financings, including acquisitions, add-ons, and refinancings
  • Asset-based transactions, including IP-backed, recurring revenue, accounts receivable, inventory, data center, and equipment financings
  • Structured equity and pre-IPO financings

Dan previously served on Latham’s Training and Career Enhancement Committee (TACE) and has been recognized within the firm as an excellent supervisor and leading supporter of recruiting and knowledge management efforts. He is an ally member of the Latham’s Hispanic/Latin American Lawyers Group.

He also serves on Stanford’s Bing Overseas Study Program Advisory Council and the Duke Law Alumni Association Board of Directors.

Technology

Dan has advised on a variety of debt transactions in the technology industry, including those involving digital assets, cryptocurrency, Web3, cloud services, artificial intelligence (AI), and agtech, including:

  • Appodeal
  • Axios
  • Bright Machines
  • Canva
  • EasyPost
  • Examity
  • FUBOTV INC.
  • Inevitable Tech Inc
  • ironSource
  • Kandji
  • Nanosys
  • Owlet
  • Spot AI
  • Tarana Wireless

Life Sciences

Dan has advised on a variety of debt transactions in the healthcare and life sciences industries, including those involving medical device manufacturers, and pharmaceutical and biotech companies, including:

  • Alignment Healthcare
  • ATAI Life Sciences
  • BridgeBio
  • Centrexion
  • Coherus
  • Corium
  • Everly Health
  • KSQ Therapeutics
  • Neurelis
  • Phathom Pharmaceuticals
  • scPharmaceuticals
  • Sight Sciences

Venture Capital, Private Equity, Private Capital and Asset Managers

Dan regularly represents venture capital. private equity and other private capital firms in connection with private and public investments, acquisitions, and divestitures, including:

  • 8VC
  • Blue Owl Credit Advisors
  • Flagship Pioneering
  • Golub Capital
  • Hercules Capital
  • Kennedy Lewis Investment Management
  • Khosla Ventures
  • Marathon Capital 
  • North Haven Tactical Fund
  • Blue Owl Capital
  • SLR Investment Corp.
  • Trinity Capital Investments

Bar Qualification

  • California
  • New York

Education

  • JD in Education, Duke University School of Law, 2009
    Editor, Duke Law Journal and Duke Law & Technology Review
  • LLM, Duke University, 2009
  • BA, Stanford University, 2005
    with honors
Badges and Logos_Law360_Fintech Group of the Year_2024
February 20, 2025 Recognition

Fintech Group of the Year: Latham

Firm honored by Law360 for advising startups, financial institutions, VCs, digital asset and Web3 participants, and corporations on their most innovative and complex transactions, investigations, litigation, and regulatory matters.